Belgium· BE-AMP-SAM661176-00
Tezspire 210 mg
A tezepelumab product containing tezepelumab, registered in Belgium by AstraZeneca. The same ATC class is registered in 16 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Tezepelumab is registered in 16 of 19 countries.
Countries holding a registration under ATC R03DX11 (tezepelumab), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 10 of them publish a price we can compare per daily dose
Tezepelumab · ATC R03DX11
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tezepelumab costs, country by country.
Normalised to the WHO defined daily dose (7.5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tezepelumab · price per daily dose (7.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$48.28
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Tezepelumab
- Manufacturer
- AstraZeneca
- Country
- Belgium (BE)
- ATC code
- R03DX11
- ATC class
- Tezepelumab
- Defined daily dose
- 7.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 3
2 priced- be_apb7740947
- be_apb4826590EUR 3597.14
- be_apb4688164EUR 1206.36
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tezepelumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTEZSPIREAstraZeneca AB, Södertälje
- SpainTEZSPIRE 210 MG SOLUCION INYECTABLE EN JERINGA PRECARGADAAstrazeneca Ab
- IcelandTezspireAstraZeneca AB*
- NorwayTezspireAstraZeneca AB (2)
- SwedenTezspire 210 mg Injektionsvätska, lösning i förfylld injektionspennaAstraZeneca AB
- PolandTezspireAstraZeneca AB
- United StatesTEZSPIREAmgen Inc
- FinlandTezspireAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tezspire
- Liechtenstein · Tezspire
- Norway · Tezspire
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fd366f7d-ee3b-4e53-a95c-b07626408c58 GET /v1/drugs/fd366f7d-ee3b-4e53-a95c-b07626408c58?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled pen",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Tezspire 210 mg",
"name_fr": "Tezspire 210 mg",
"name_nl": "Tezspire 210 mg",
"amp_code": "SAM661176-00",
"strengths": [
"110.0000",
"110.0000"
],
"pack_count": 3,
"substances": [
"Tezepelumab",
"Proline",
"Sodium Hydroxide",
"Polysorbate 80"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Tezepelumab",
"authorisation_numbers": [
"EU/1/22/1677/003",
"EU/1/22/1677/004"
]
}See everything about tezepelumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.